Global Cystic Fibrosis Therapeutics Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)


    Table of Contents

      1. Preface

      • 1.1. Objectives of the Study
      • 1.2. Market Segmentation & Coverage
      • 1.3. Years Considered for the Study
      • 1.4. Currency & Pricing
      • 1.5. Stakeholders

      2. Research & Forecasting

      • 2.1. Research Methodology
        • 2.1.1. Research Instruments
          • 2.1.1.1. Secondary Instrument
          • 2.1.1.2. Primary Instrument
        • 2.1.2. Research Approaches
          • 2.1.2.1. Bottom-up Approach
          • 2.1.2.2. Top-down Approach
        • 2.1.3. Research Reliability & Validity
        • 2.1.4. Research Assumptions
        • 2.1.5. Vendor Inclusion Criteria
      • 2.2. Forecasting Methodology
        • 2.2.1. Methodology for Market Estimation & Forecasting
        • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

      3. Executive Summary

        4. Premium Insight

        • 4.1. Market Connectivity
        • 4.2. Market Data Feed
        • 4.3. Market Vendor Ranking Analysis
        • 4.4. Market Dynamics
          • 4.4.1. Drivers
            • 4.4.1.1. Improved diagnostic technologies
            • 4.4.1.2. Rising prevalence of Cystic Fibrosis
            • 4.4.1.3. Increasing global awareness for Cystic Fibrosis
            • 4.4.1.4. Research & development activities
            • 4.4.1.5. Robust drug development pipeline
            • 4.4.1.6. Favorable initiatives taken by NGOs, government, and private companies
          • 4.4.2. Restraints
            • 4.4.2.1. Expiring patents and generic drugs
            • 4.4.2.2. Increase in genetic mutation rate
          • 4.4.3. Opportunities
            • 4.4.3.1. Increasing demand from emerging economies
            • 4.4.3.2. Growing strategic collaborations and Merger & Acquisition
          • 4.4.4. Challenges
            • 4.4.4.1. High cost involved in treatment and complicated pathophysiology
        • 4.5. Porter’s Five Forces Analysis
          • 4.5.1. Threat of New Entrants
          • 4.5.2. Threat of Substitutes
          • 4.5.3. Bargaining Power of Customers
          • 4.5.4. Bargaining Power of Suppliers
          • 4.5.5. Industry Rivalry
        • 4.6. Advances in Technology for Drug Development and Delivery

        5. Global Cystic Fibrosis Therapeutics Market, by Drug Class

        • 5.1. Introduction
        • 5.2. Anti-Infectives
        • 5.3. Bronchodilators
        • 5.4. CFTR Modulators
        • 5.5. Mucolytics
        • 5.6. PERT

        6. Global Cystic Fibrosis Therapeutics Market, by Type

        • 6.1. Introduction
        • 6.2. Inhaled Drugs
        • 6.3. Oral Drugs

        7. Global Cystic Fibrosis Therapeutics Market, by Geography

        • 7.1. Introduction
        • 7.2. Americas Cystic Fibrosis Therapeutics Market
          • 7.2.1. Americas Cystic Fibrosis Therapeutics Market, by Country
            • 7.2.1.1. United States
            • 7.2.1.2. Brazil
            • 7.2.1.3. Canada
            • 7.2.1.4. Mexico
            • 7.2.1.5. Argentina
          • 7.2.2. Americas Cystic Fibrosis Therapeutics Market, by Drug Class
          • 7.2.3. Americas Cystic Fibrosis Therapeutics Market, by Type
        • 7.3. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market
          • 7.3.1. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Country
            • 7.3.1.1. United Kingdom
            • 7.3.1.2. Germany
            • 7.3.1.3. France
            • 7.3.1.4. Saudi Arabia
            • 7.3.1.5. United Arab Emirates
            • 7.3.1.6. Italy
            • 7.3.1.7. Russia
          • 7.3.2. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Drug Class
          • 7.3.3. Europe, Middle East & Africa Cystic Fibrosis Therapeutics Market, by Type
        • 7.4. Asia-Pacific Cystic Fibrosis Therapeutics Market
          • 7.4.1. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Country
            • 7.4.1.1. China
            • 7.4.1.2. Japan
            • 7.4.1.3. India
            • 7.4.1.4. Australia
          • 7.4.2. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Drug Class
          • 7.4.3. Asia-Pacific Cystic Fibrosis Therapeutics Market, by Type

        8. 360iResearch Competitive Strategic Window

        • 8.1. Introduction
          • 8.1.1. Leverage Zone
          • 8.1.2. Vantage Zone
          • 8.1.3. Speculative Zone
          • 8.1.4. Bottleneck Zone

        9. 360iResearch FPNV Positioning Matrix

        • 9.1. Introduction
        • 9.2. 360iResearch Scores
          • 9.2.1. Forefront
          • 9.2.2. Pathfinders
          • 9.2.3. Niche
          • 9.2.4. Vital
        • 9.3. Business Strategy
        • 9.4. Product Satisfaction

        10. Competitive News Feed Analysis

          11. Company Usability Profiles

          • 11.1. AbbVie Inc.
          • 11.2. Alaxia
          • 11.3. Alcresta Therapeutics, Inc.
          • 11.4. Allergan plc
          • 11.5. AstraZeneca PLC
          • 11.6. Chiesi Pharmaceuticals B.V.
          • 11.7. F. Hoffmann-La Roche Ltd
          • 11.8. Genentech, Inc.
          • 11.9. Gilead Sciences, Inc.
          • 11.10. Merck & Co., Inc.
          • 11.11. Novartis International AG
          • 11.12. Pharmaxis Ltd
          • 11.13. Teva Pharmaceutical Industries Limited
          • 11.14. Vertex Pharmaceuticals Incorporated

          12. Appendix

          • 12.1. Top Reports
          • 12.2. Author Details

          LIST OF TABLES (27 TABLES)

            TABLE 1. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

              TABLE 2. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET RANKING, BY VENDORS, 2017

                TABLE 3. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

                  TABLE 4. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                    TABLE 5. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                      TABLE 6. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                        TABLE 7. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                          TABLE 8. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY PERT, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                            TABLE 9. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

                              TABLE 10. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                TABLE 11. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                  TABLE 12. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

                                    TABLE 13. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                      TABLE 14. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

                                        TABLE 15. AMERICAS CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

                                          TABLE 16. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                            TABLE 17. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

                                              TABLE 18. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

                                                TABLE 19. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                  TABLE 20. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2016 - 2024 (USD BILLION)

                                                    TABLE 21. ASIA-PACIFIC CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

                                                      TABLE 22. 360IRESEARCH SCORES FOR FOREFRONT IN CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                        TABLE 23. 360IRESEARCH SCORES FOR PATHFINDERS IN CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                          TABLE 24. 360IRESEARCH SCORES FOR NICHE IN CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                            TABLE 25. 360IRESEARCH SCORES FOR VITAL IN CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                              TABLE 26. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                                TABLE 27. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                                  LIST OF FIGURES (25 TABLES)

                                                                    FIGURE 1. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: YEARS CONSIDERED FOR THE STUDY

                                                                      FIGURE 2. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH METHODOLOGY

                                                                        FIGURE 3. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH INSTRUMENTS

                                                                          FIGURE 4. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY SECONDARY INSTRUMENT SOURCES

                                                                            FIGURE 5. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY POTENTIAL RESPONDENTS

                                                                              FIGURE 6. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

                                                                                FIGURE 7. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH APPROACHES

                                                                                  FIGURE 8. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY DATA TRIANGULATION

                                                                                    FIGURE 9. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY RESEARCH ASSUMPTIONS

                                                                                      FIGURE 10. CYSTIC FIBROSIS THERAPEUTICS MARKET: KEY MARKET CONNECTIVITY

                                                                                        FIGURE 11. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, 2016 - 2024 (USD BILLION)

                                                                                          FIGURE 12. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017 VS 2024 (USD BILLION)

                                                                                            FIGURE 13. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                              FIGURE 14. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                FIGURE 15. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                  FIGURE 16. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                    FIGURE 17. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY PERT, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                      FIGURE 18. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD BILLION)

                                                                                                        FIGURE 19. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                          FIGURE 20. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

                                                                                                            FIGURE 21. GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)

                                                                                                              FIGURE 22. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY DRUG CLASS, 2024

                                                                                                                FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY TYPE, 2024

                                                                                                                  FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET, BY GEOGRAPHY, 2024

                                                                                                                    FIGURE 25. 360IRESEARCH FPNV POSITIONING MATRIX FOR CYSTIC FIBROSIS THERAPEUTICS MARKET

                                                                                                                    The global cystic fibrosis therapeutics market is expected to grow from USD 3.73 billion 2017 to USD 10.86 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 16.50%.

                                                                                                                    “Improved diagnostic technologiesis one of the factors largely attributing to the growth of cystic fibrosis therapeutics market globally”

                                                                                                                    The factors attributing to the growth of the market are improved diagnostic technologies, rising prevalence of cystic fibrosis, increasing global awareness for cystic fibrosis, research & development activities, robust drug development pipeline, and favorable initiatives taken by ngos, government, and private companies. However, some factors such as expiring patents and generic drugs, and increase in genetic mutation rate may hinder the market growth. The global cystic fibrosis therapeutics market is expected to showcase the opportunities such as increasing demand from emerging economies, and growing strategic collaborations and merger & acquisition. In the near future, the market may face the possible challenges in the growth due to and high cost involved in treatment and complicated pathophysiology. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global cystic fibrosis therapeutics market market.

                                                                                                                    On the basis of drug class, the global cystic fibrosis therapeutics market is studied across Anti-Infectives, Bronchodilators, CFTR Modulators, Mucolytics, and PERT.

                                                                                                                    On the basis of type, the global cystic fibrosis therapeutics market is studied across Inhaled Drugs and Oral Drugs.

                                                                                                                    On the basis of geography, the global cystic fibrosis therapeutics market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

                                                                                                                    “AbbVie Inc.: The potential growing player for the global cystic fibrosis therapeutics market”

                                                                                                                    The key players profiled in the global cystic fibrosis therapeutics market are AbbVie Inc., Alaxia, Alcresta Therapeutics, Inc., Allergan plc, AstraZeneca PLC, Chiesi Pharmaceuticals B.V., F. Hoffmann-La Roche Ltd, Genentech, Inc., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Pharmaxis Ltd, Teva Pharmaceutical Industries Limited, and Vertex Pharmaceuticals Incorporated.

                                                                                                                    The report provides insights on the following pointers:
                                                                                                                    1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global cystic fibrosis therapeutics market.
                                                                                                                    2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global cystic fibrosis therapeutics market.
                                                                                                                    3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global cystic fibrosis therapeutics market.
                                                                                                                    4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global cystic fibrosis therapeutics market.
                                                                                                                    5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global cystic fibrosis therapeutics market.



                                                                                                                    Summary:
                                                                                                                    Cystic Fibrosis Therapeutics Market Research Report is about Cystic Fibrosis Therapeutics Industry study. Get complete Cystic Fibrosis Therapeutics market research report published after Market Study, Industrial Analysis with Trends & Statistics. Cystic Fibrosis Therapeutics Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



                                                                                                                    REPORT YOU MIGHT BE INTERESTED